SINTX Technologies expects SiN/PEEK filament from Evonik before year-end 2026 and pursues FDA 510(k) clearance

SINTX Technologies expects SiN/PEEK filament from Evonik before year-end 2026 and is pursuing FDA 510(k) clearance. It is evaluating custom device qualification opportunities in Q1 2027 and anticipates expansion into CMF and spinal applications later that year.